CAXTON CORP Diversified Active

Location: Princeton, NJ

CIK: 0001388551 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value: $16.64M (100.0% shares, 0.0% debt)

Holdings (15)

XERS XERIS BIOPHARMA HOLDINGS INC 41.1%

Value $6.831M Shares 2,015,157 Share Price $3.39 * Est. Cost/Share $2.16 Unrealized @ Report Date +48.9%

RZLT REZOLUTE INC 38.8%

Value $6.463M Shares 1,318,967 Share Price $4.90 * Est. Cost/Share $9.52 Unrealized @ Report Date -47.1%

SPY SPDR S&P 500 ETF TR 9.9%

Value $1.654M Shares 2,823 Share Price $586.08 Est. Cost/Share $518.47 Unrealized @ Report Date —

BRK/B BERKSHIRE HATHAWAY INC DEL 3.1%

Value $514K Shares 1,133 Share Price $453.27 Est. Cost/Share $360.98 Unrealized @ Report Date +27.9%

GLD SPDR GOLD TR 1.7%

Value $283K Shares 1,169 Share Price $242.15 Est. Cost/Share $242.15 Unrealized @ Report Date —

— MIND MEDICINE MINDMED INC 1.4%

Value $237K Shares 34,073 Share Price $6.96 Est. Cost/Share $8.91 Unrealized @ Report Date —

BCAX BICARA THERAPEUTICS INC 1.1%

Value $191K Shares 10,941 Share Price $17.42 * Est. Cost/Share $25.50 Unrealized @ Report Date -18.4%

LXEO LEXEO THERAPEUTICS INC 0.7%

Value $117K Shares 17,851 Share Price $6.58 * Est. Cost/Share $13.31 Unrealized @ Report Date -40.8%

KYTX KYVERNA THERAPEUTICS INC 0.5%

Value $85,950 Shares 22,981 Share Price $3.74 * Est. Cost/Share $23.94 Unrealized @ Report Date -80.0%

CMPX COMPASS THERAPEUTICS INC 0.4%

Value $63,025 Shares 43,465 Share Price $1.45 * Est. Cost/Share $3.23 Unrealized @ Report Date -48.6%

CRDF CARDIFF ONCOLOGY INC 0.3%

Value $57,665 Shares 13,287 Share Price $4.34 * Est. Cost/Share $3.13 Unrealized @ Report Date 0.0%

IKT INHIBIKASE THERAPEUTICS INC 0.3%

Value $53,277 Shares 16,393 Share Price $3.25 * Est. Cost/Share $2.49 Unrealized @ Report Date 0.0%

— GLYCOMIMETICS INC 0.3%

Value $50,895 Shares 203,578 Share Price $0.25 Est. Cost/Share $0.25 Unrealized @ Report Date —

CNTX CONTEXT THERAPEUTICS INC 0.1%

Value $19,324 Shares 18,403 Share Price $1.05 * Est. Cost/Share $1.72 Unrealized @ Report Date +0.4%

— ADICET BIO INC 0.1%

Value $16,823 Shares 17,488 Share Price $0.96 Est. Cost/Share $2.35 Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
XERS	XERIS BIOPHARMA HOLDINGS INC	2,015,157	$6.831M	41.1%	$3.39 *	$2.16	+48.9%	COM	98422E103
RZLT	REZOLUTE INC	1,318,967	$6.463M	38.8%	$4.90 *	$9.52	-47.1%	COM NEW	76200L309
SPY	SPDR S&P 500 ETF TR	2,823	$1.654M	9.9%	$586.08	$518.47	—	TR UNIT	78462F103
BRK/B	BERKSHIRE HATHAWAY INC DEL	1,133	$514K	3.1%	$453.27	$360.98	+27.9%	CL B NEW	084670702
GLD	SPDR GOLD TR	1,169	$283K	1.7%	$242.15	$242.15	—	GOLD SHS	78463V107
—	MIND MEDICINE MINDMED INC	34,073	$237K	1.4%	$6.96	$8.91	—	COM NEW	60255C885
BCAX	BICARA THERAPEUTICS INC	10,941	$191K	1.1%	$17.42 *	$25.50	-18.4%	COM	055477103
LXEO	LEXEO THERAPEUTICS INC	17,851	$117K	0.7%	$6.58 *	$13.31	-40.8%	COM	52886X107
KYTX	KYVERNA THERAPEUTICS INC	22,981	$85,950	0.5%	$3.74 *	$23.94	-80.0%	COM	501976104
CMPX	COMPASS THERAPEUTICS INC	43,465	$63,025	0.4%	$1.45 *	$3.23	-48.6%	COM	20454B104
CRDF	CARDIFF ONCOLOGY INC	13,287	$57,665	0.3%	$4.34 *	$3.13	0.0%	COM	14147L108
IKT	INHIBIKASE THERAPEUTICS INC	16,393	$53,277	0.3%	$3.25 *	$2.49	0.0%	COM NEW	45719W205
—	GLYCOMIMETICS INC	203,578	$50,895	0.3%	$0.25	$0.25	—	COM	38000Q102
CNTX	CONTEXT THERAPEUTICS INC	18,403	$19,324	0.1%	$1.05 *	$1.72	+0.4%	COM	21077P108
—	ADICET BIO INC	17,488	$16,823	0.1%	$0.96	$2.35	—	COM	007002108